Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients

被引：0
|
作者：
Matson, Vyara [1 ]
Fessler, Jessica [1 ]
Bao, Riyue [1 ]
Chongsuwat, Tara [1 ]
Zha, Yuanyuan [1 ]
Alegre, Maria-Luisa [1 ]
Luke, Jason [1 ]
Gajewski, Thomas [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P394
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
  • [32] Proteomic biomarker analysis of metastatic melanoma patients treated with anti-PD-1 checkpoint blockade
    Ascierto, Paolo Antonio
    Capone, Mariaelena
    Grimaldi, Antonio Maria
    Mallardo, Domenico
    Simeone, Ester
    Roder, Heinrich
    Meyer, Krista
    Asmellash, Senait
    Oliveira, Carlos
    Roder, Joanna
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [33] Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
    Bhave, Prachi
    Ahmed, Tasnia
    Lo, Serigne N.
    Shoushtari, Alexander
    Zaremba, Anne
    Versluis, Judith M.
    Mangana, Joanna
    Weichenthal, Michael
    Si, Lu
    Lesimple, Thierry
    Robert, Caroline
    Trojanello, Claudia
    Wicky, Alexandre
    Heywood, Richard
    Tran, Lena
    Batty, Kathleen
    Dimitriou, Florentia
    Stansfeld, Anna
    Allayous, Clara
    Schwarze, Julia K.
    Mooradian, Meghan J.
    Klein, Oliver
    Mehmi, Inderjit
    Roberts-Thomson, Rachel
    Maurichi, Andrea
    Yeoh, Hui-Ling
    Khattak, Adnan
    Zimmer, Lisa
    Blank, Christian U.
    Ramelyte, Egle
    Kaehler, Katharina C.
    Roy, Severine
    Ascierto, Paolo A.
    Michielin, Olivier
    Lorigan, Paul C.
    Johnson, Douglas B.
    Plummer, Ruth
    Lebbe, Celeste
    Neyns, Bart
    Sullivan, Ryan
    Hamid, Omid
    Santinami, Mario
    McArthur, Grant A.
    Haydon, Andrew M.
    Long, Georgina, V
    Menzies, Alexander M.
    Carlino, Matteo S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (07)
  • [34] Comparison of the efficacy and toxicity of anti-PD-1 monoclonal antibodies (nivolumab versus pembrolizumab) in treatment of patients with metastatic melanoma.
    Cybulska-Stopa, Bozena
    Zietek, Marcin
    Czarnecka, Anna Malgorzata
    Piejko, Karolina
    Dziura, Robert
    Galus, Lukasz
    Ziolkowska, Barbara
    Kieszko, Stanislaw
    Kempa-Kaminska, Natasza
    Calik, Jacek
    Gajewska-Wicher, Katarzyna
    Gadek, Kamila
    Salek-Zan, Agata
    Seredynska, Joanna
    Drosik-Kwasniewska, Anna
    Kaminska-Winciorek, Grazyna
    Kubiatowski, Tomasz
    Suwinski, Rafal
    Mackiewicz, Jacek
    Rutkowski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Germline variation in PDCD1 is associated with survival in metastatic melanoma after anti-PD-1 monotherapy
    De With, M.
    Hurkmans, D. P.
    Oomen-de Hoop, E.
    Lalouti, A.
    Bins, S.
    El Bouazzaoui, S.
    Debets, R.
    Aerts, J. G.
    Van Schaik, R. H. N.
    Mathijssen, R. H.
    Van der Veldt, A. A. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S758 - S758
  • [36] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
    Bowyer, S.
    Prithviraj, P.
    Lorigan, P.
    Larkin, J.
    McArthur, G.
    Atkinson, V.
    Millward, M.
    Khou, M.
    Diem, S.
    Ramanujam, S.
    Kong, B.
    Liniker, E.
    Guminski, A.
    Parente, P.
    Andrews, M. C.
    Parakh, S.
    Cebon, J.
    Long, G. V.
    Carlino, M. S.
    Klein, O.
    BRITISH JOURNAL OF CANCER, 2016, 114 (10) : 1084 - 1089
  • [37] Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma
    Hoshi, Yuta
    Enokida, Tomohiro
    Tamura, Shingo
    Nakashima, Torahiko
    Okano, Susumu
    Fujisawa, Takao
    Sato, Masanobu
    Wada, Akihisa
    Tanaka, Hideki
    Takeshita, Naohiro
    Tanaka, Nobukazu
    Onaga, Ryutaro
    Kishida, Takuma
    Uryu, Hideoki
    Sakashita, Shingo
    Asakage, Takahiro
    Tahara, Makoto
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [38] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
    S Bowyer
    P Prithviraj
    P Lorigan
    J Larkin
    G McArthur
    V Atkinson
    M Millward
    M Khou
    S Diem
    S Ramanujam
    B Kong
    E Liniker
    A Guminski
    P Parente
    M C Andrews
    S Parakh
    J Cebon
    G V Long
    M S Carlino
    O Klein
    British Journal of Cancer, 2016, 114 : 1084 - 1089
  • [39] Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
    Shi, Guilan
    Scott, Megan
    Mangiamele, Cathryn G.
    Heller, Richard
    PHARMACEUTICS, 2022, 14 (11)
  • [40] Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma
    Kong, Benjamin Y.
    Micklethwaite, Kenneth P.
    Swaminathan, Sanjay
    Kefford, Richard F.
    Carlino, Matteo S.
    MELANOMA RESEARCH, 2016, 26 (02) : 202 - 204
12345